• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

墨西哥恰帕斯州洛斯阿尔托斯、塞尔瓦和诺尔特地区的耐多药肺结核。

Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico.

机构信息

Area Académica de Sociedad, Cultura y Salud, El Colegio de la Frontera Sur, San Cristóbal de Las Casas, Chiapas, México.

出版信息

Int J Tuberc Lung Dis. 2010 Jan;14(1):34-9.

PMID:20003692
Abstract

OBJECTIVES

To analyse the proportion of multidrug-resistant tuberculosis (MDR-TB) in cultures performed during the period 2000-2002 in Los Altos, Selva and Norte regions, Chiapas, Mexico, and to analyse MDR-TB in terms of clinical and sociodemographic indicators.

METHODS

Cross-sectional study of patients with pulmonary tuberculosis (PTB) from the above regions. Drug susceptibility testing results from two research projects were analysed, as were those of routine sputum samples sent in by health personnel for processing (n = 114). MDR-TB was analysed in terms of the various variables of interest using bivariate tests of association and logistic regression.

RESULTS

The proportion of primary MDR-TB was 4.6% (2 of 43), that of secondary MDR-TB was 29.2% (7/24), while among those whose history of treatment was unknown the proportion was 14.3% (3/21). According to the logistic regression model, the variables most highly associated with MDR-TB were as follows: having received anti-tuberculosis treatment previously, cough of >3 years' duration and not being indigenous.

CONCLUSIONS

The high proportion of MDR cases found in the regions studied shows that it is necessary to significantly improve the control and surveillance of PTB.

摘要

目的

分析 2000-2002 年期间在墨西哥恰帕斯州洛斯阿尔托斯、塞尔瓦和诺特地区进行的培养物中耐多药结核病(MDR-TB)的比例,并分析临床和社会人口学指标方面的 MDR-TB。

方法

对来自上述地区的肺结核(PTB)患者进行横断面研究。分析了两个研究项目的药敏试验结果,以及卫生人员为处理而送检的常规痰样本(n=114)的结果。使用关联的双变量检验和逻辑回归分析,对 MDR-TB 与各种感兴趣变量进行分析。

结果

原发性 MDR-TB 的比例为 4.6%(43 例中的 2 例),继发性 MDR-TB 的比例为 29.2%(24 例中的 7 例),而对于治疗史未知的患者,其比例为 14.3%(21 例中的 3 例)。根据逻辑回归模型,与 MDR-TB 最相关的变量如下:之前接受过抗结核治疗、咳嗽时间>3 年以及非原住民。

结论

在所研究的地区发现的大量 MDR 病例表明,有必要显著加强对 PTB 的控制和监测。

相似文献

1
Multidrug-resistant pulmonary tuberculosis in Los Altos, Selva and Norte regions, Chiapas, Mexico.墨西哥恰帕斯州洛斯阿尔托斯、塞尔瓦和诺尔特地区的耐多药肺结核。
Int J Tuberc Lung Dis. 2010 Jan;14(1):34-9.
2
Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.泰国孔敬府诗里拉吉医院的耐多药结核病
Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):570-4.
3
First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.伊朗国家结核病转诊中心一线抗结核药物耐药模式及趋势——八年监测情况
Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.
4
Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴新诊断涂片阳性肺结核患者的原发性耐药情况。
Ethiop Med J. 2008 Oct;46(4):367-74.
5
Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.菲律宾马尼拉市菲律宾总医院收治患者的耐药性质及耐多药结核病的预测因素
Int J Tuberc Lung Dis. 1997 Feb;1(1):59-63.
6
Extensively drug-resistant tuberculosis in california, 1993-2006.1993 - 2006年加利福尼亚州的广泛耐药结核病
Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.
7
Demographic, health services and socio-economic factors associated with pulmonary tuberculosis mortality in Los Altos Region of Chiapas, Mexico.墨西哥恰帕斯州洛斯阿尔托斯地区与肺结核死亡率相关的人口统计学、卫生服务及社会经济因素
Int J Epidemiol. 2008 Aug;37(4):786-95. doi: 10.1093/ije/dyn089. Epub 2008 May 29.
8
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.未感染艾滋病毒的耐多药和广泛耐药结核病患者的治疗结果。
Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.
9
Pilot study on multidrug resistant tuberculosis in Nigeria.尼日利亚耐多药结核病的试点研究。
Ann Afr Med. 2010 Jul-Sep;9(3):184-7. doi: 10.4103/1596-3519.68355.
10
In vitro drug resistance and response to therapy in pulmonary tuberculosis patients under a DOTS programme in south India.印度南部直接观察治疗短程化疗(DOTS)项目下肺结核患者的体外耐药性及治疗反应
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):564-70. doi: 10.1016/j.trstmh.2009.01.005. Epub 2009 Feb 24.

引用本文的文献

1
Tuberculosis treatment failure: what are the risk factors? A comprehensive literature review.肺结核治疗失败:危险因素有哪些?一项综合性文献综述。
Multidiscip Respir Med. 2025 Jul 4;20(1):1030. doi: 10.5826/mrm.2025.1030.
2
Sociodemographic factors associated with the success or failure of anti-tuberculosis treatment in the Chiapas Highlands, Mexico, 2019-2022.2019 - 2022年墨西哥恰帕斯高地与抗结核治疗成败相关的社会人口学因素
PLoS One. 2024 Jan 26;19(1):e0296924. doi: 10.1371/journal.pone.0296924. eCollection 2024.
3
Genetic Diversity of Isolates From an Amerindian Population in Chiapas, México.
来自墨西哥恰帕斯州美洲印第安人群体的分离株的遗传多样性。
Front Cell Infect Microbiol. 2022 Jul 13;12:875909. doi: 10.3389/fcimb.2022.875909. eCollection 2022.
4
Detailed epidemiological analysis as a strategy for evaluating the actual behavior of tuberculosis in an apparently low-incidence region.详细的流行病学分析作为评估明显低发病率地区结核病实际行为的策略。
Pathog Glob Health. 2020 Oct;114(7):393-404. doi: 10.1080/20477724.2020.1813488. Epub 2020 Sep 14.
5
Tuberculosis Care in Mexico's Chiapas Highlands Region: A Right to Health Analysis.墨西哥恰帕斯高地地区的结核病护理:一项健康权分析。
Health Hum Rights. 2020 Jun;22(1):305-316.
6
Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.糖尿病、营养不良、移民和土著社区:墨西哥恰帕斯的结核病。
Epidemiol Infect. 2019 Jan;147:e71. doi: 10.1017/S0950268818003461.
7
Magnetic Nanoparticle-Based Biosensing Assay Quantitatively Enhances Acid-Fast Bacilli Count in Paucibacillary Pulmonary Tuberculosis.基于磁性纳米粒子的生物传感分析定量增强了少菌型肺结核中抗酸杆菌的计数。
Biosensors (Basel). 2018 Dec 12;8(4):128. doi: 10.3390/bios8040128.
8
Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh.孟加拉国卫生系统在耐多药结核病患者治疗方面的延误。
BMC Infect Dis. 2015 Nov 16;15:526. doi: 10.1186/s12879-015-1253-9.
9
Health-service performance of TB treatment for indigenous and non-indigenous populations in Brazil: a cross-sectional study.巴西本土和非本土人群结核病治疗的卫生服务绩效:一项横断面研究。
BMC Health Serv Res. 2014 May 23;14:237. doi: 10.1186/1472-6963-14-237.
10
Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China.在结核病负担沉重的国家,我们在遏制获得性耐多药结核病的浪潮方面做得够吗?中国重庆一项混合方法研究的结果。
PLoS One. 2014 Feb 5;9(2):e88330. doi: 10.1371/journal.pone.0088330. eCollection 2014.